The influence of lactulose on endotoxin and liver function after hepatic ischemia

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001030

Enrollment

Unknown

Registered

2010-09-28

Start date

2010-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign or malignant liver disease

Interventions

Group A:bowel preparation with lactulose

Group B:bowel preparation with glycerine enema

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 18 to 70 years old; 2. Able and willing to provide signed informed consent; 3. Liver disease patients needing operation; 4. Liver function: Child-Pugh A

Exclusion criteria

Exclusion criteria: 1. Liver function: Child-Pugh B and C; 2. Patients with severe heart or renal or blood disease; 3. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
endotoxin level;liver function;	—

Countries

China

Contacts

Public ContactJingjian Sun

zooperxhz@126.com+86 13701916217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026